Interview
Interviews are typically with authors on their recently published AJKD articles.
Rituximab effectively limits the number of relapses in childhood idiopathic nephrotic syndromes (INS) and reduces exposure to corticosteroids and other immunosuppressants.
[...]Atrial fibrillation is common among patients with kidney failure treated with hemodialysis. A recent study published in AJKD by Winkelmayer et al examined the efficacy and
[...]IgA nephropathy (IgAN) is the most common immune-mediated glomerular disease worldwide. Advanced understanding of the role of complement in IgAN pathogenesis has motivated
[...]Systemic lupus erythematosus (SLE) is a chronic, multiorgan autoimmune disease, with lupus nephritis (LN) affecting up to 60% of patients. Early diagnosis and treatment are
[...]Hyperphosphatemia remains a major challenge in managing patients with kidney failure and is associated with significant morbidity and mortality. In a Mini-Review recently
[...]Chronic systemic inflammation, triggered by innate immune system activation, is a key driver of both chronic kidney disease (CKD) and associated atherosclerosis and
[...]Membranous nephropathy (MN) is characterized by a relapsing remitting course with a third of patients developing kidney failure if untreated. A recent study published in AJKD
[...]Glucagon-like peptide-1 receptor agonists and sodium/glucose cotransporter 2 (SGLT2) inhibitors can improve outcomes in patients with type 2 diabetes. Using a nationwide
[...]Hispanics, the largest ethnic minority group in the United States, experience faster progression of chronic kidney disease to kidney failure compared with non-Hispanic White
[...]Proteinuria plays a central role in the diagnosis of kidney disease and has a high prognostic value. The test methods used differ considerably regarding their impact on test
[...]
